Cite
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound
MLA
Gomes, Tatiana F., et al. “Biotransformation of LASSBio-579 and Pharmacological Evaluation of p-Hydroxylated Metabolite a N-Phenylpiperazine Antipsychotic Lead Compound.” European Journal of Medicinal Chemistry, vol. 62, Apr. 2013, pp. 214–21. EBSCOhost, https://doi.org/10.1016/j.ejmech.2012.08.011.
APA
Gomes, T. F., Pompeu, T. E. T., Rodrigues, D. A., Noël, F., Menegatti, R., Andrade, C. H., Sabino, J. R., Gil, E. S., Dalla Costa, T., Betti, A. H., Antonio, C. B., Rates, S. M. K., Fraga, C. A. M., Barreiro, E. J., & de Oliveira, V. (2013). Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound. European Journal of Medicinal Chemistry, 62, 214–221. https://doi.org/10.1016/j.ejmech.2012.08.011
Chicago
Gomes, Tatiana F., Thais E.T. Pompeu, Daniel A. Rodrigues, François Noël, Ricardo Menegatti, Carolina H. Andrade, José R. Sabino, et al. 2013. “Biotransformation of LASSBio-579 and Pharmacological Evaluation of p-Hydroxylated Metabolite a N-Phenylpiperazine Antipsychotic Lead Compound.” European Journal of Medicinal Chemistry 62 (April): 214–21. doi:10.1016/j.ejmech.2012.08.011.